BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 29319548)

  • 1. Routine Assessment of Patient Index Data 3 Score and Psoriasis Quality of Life Assess Complementary Yet Different Aspects of Patient-Reported Outcomes in Psoriasis and Psoriatic Arthritis.
    Vakil-Gilani KM; Dinno A; Rich-Garg N; Deodhar A
    J Clin Rheumatol; 2018 Sep; 24(6):319-323. PubMed ID: 29319548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life and contact with healthcare systems among patients with psoriasis and psoriatic arthritis: results from the NORdic PAtient survey of Psoriasis and Psoriatic arthritis (NORPAPP).
    Duvetorp A; Østergaard M; Skov L; Seifert O; Tveit KS; Danielsen K; Iversen L
    Arch Dermatol Res; 2019 Jul; 311(5):351-360. PubMed ID: 30868221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utilization of the validated Psoriasis Epidemiology Screening Tool to identify signs and symptoms of psoriatic arthritis among those with psoriasis: a cross-sectional analysis from the US-based Corrona Psoriasis Registry.
    Mease PJ; Palmer JB; Hur P; Strober BE; Lebwohl M; Karki C; Reed GW; Etzel CJ; Greenberg JD; Helliwell PS
    J Eur Acad Dermatol Venereol; 2019 May; 33(5):886-892. PubMed ID: 30663130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measuring Outcomes in Psoriatic Arthritis: Comparing Routine Assessment of Patient Index Data and Psoriatic Arthritis Impact of Disease.
    Walsh JA; Wan MT; Willinger C; Husni ME; Scher JU; Reddy SM; Ogdie A
    J Rheumatol; 2020 Oct; 47(10):1496-1505. PubMed ID: 31575704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographics, clinical disease characteristics, and quality of life in a large cohort of psoriasis patients with and without psoriatic arthritis.
    Truong B; Rich-Garg N; Ehst BD; Deodhar AA; Ku JH; Vakil-Gilani K; Danve A; Blauvelt A
    Clin Cosmet Investig Dermatol; 2015; 8():563-9. PubMed ID: 26622188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between disease activity measured by RAPID3 and health-related quality of life in patients with rheumatoid arthritis.
    Qorolli M; Rexhepi B; Rexhepi S; Mustapić M; Doko I; Grazio S
    Rheumatol Int; 2019 May; 39(5):827-834. PubMed ID: 30847560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Value of the Routine Assessment of Patient Index Data 3 in Patients With Psoriatic Arthritis: Results From a Tight-Control Clinical Trial and an Observational Cohort.
    Coates LC; Tillett W; Shaddick G; Pincus T; Kavanaugh A; Helliwell PS
    Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1198-1205. PubMed ID: 29112801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measuring psoriatic arthritis symptoms: A core domain in psoriasis clinical trials.
    Perez-Chada LM; Gottlieb AB; Cohen J; Mease P; Duffin KC; Garg A; Latella J; Armstrong AW; Ogdie A; Merola JF
    J Am Acad Dermatol; 2020 Jan; 82(1):54-61. PubMed ID: 31163240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is the health-related quality of life and functional status of patients with psoriatic arthritis worse than that of patients with psoriasis alone?
    Tezel N; Yilmaz Tasdelen O; Bodur H; Gul U; Kulcu Cakmak S; Oguz ID; Karabulut E
    Int J Rheum Dis; 2015 Jan; 18(1):63-9. PubMed ID: 24460852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient Perspective on the Burden of Skin and Joint Symptoms of Psoriatic Arthritis: Results of a Multi-National Patient Survey.
    Merola JF; Shrom D; Eaton J; Dworkin C; Krebsbach C; Shah-Manek B; Birt J
    Rheumatol Ther; 2019 Mar; 6(1):33-45. PubMed ID: 30610650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A patient-derived and patient-reported outcome measure for assessing psoriatic arthritis: elaboration and preliminary validation of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire, a 13-country EULAR initiative.
    Gossec L; de Wit M; Kiltz U; Braun J; Kalyoncu U; Scrivo R; Maccarone M; Carton L; Otsa K; Sooäär I; Heiberg T; Bertheussen H; Cañete JD; Sánchez Lombarte A; Balanescu A; Dinte A; de Vlam K; Smolen JS; Stamm T; Niedermayer D; Békés G; Veale D; Helliwell P; Parkinson A; Luger T; Kvien TK;
    Ann Rheum Dis; 2014 Jun; 73(6):1012-9. PubMed ID: 24790067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition phase towards psoriatic arthritis: clinical and ultrasonographic characterisation of psoriatic arthralgia.
    Zabotti A; McGonagle DG; Giovannini I; Errichetti E; Zuliani F; Zanetti A; Tinazzi I; De Lucia O; Batticciotto A; Idolazzi L; Sakellariou G; Zandonella Callegher S; Sacco S; Quartuccio L; Iagnocco A; De Vita S
    RMD Open; 2019; 5(2):e001067. PubMed ID: 31749987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving international consensus on the assessment of psoriatic arthritis in psoriasis clinical trials: an International Dermatology Outcome Measures (IDEOM) initiative.
    Perez-Chada LM; Cohen JM; Gottlieb AB; Duffin KC; Garg A; Latella J; Armstrong AW; Ogdie A; Merola JF
    Arch Dermatol Res; 2018 Nov; 310(9):701-710. PubMed ID: 30167814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of life and its relation to periarticular bone changes in psoriatic patients with or without joint involvement.
    Badr S; Saad MM; Helal A; Koraym H; Tayel M; Reda I; Matrawy K; Fattah YHA
    Clin Rheumatol; 2021 Aug; 40(8):3175-3183. PubMed ID: 33634329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of Patient Perceptions of Psoriatic Disease: Results from the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) Survey.
    Lebwohl M; Langley RG; Paul C; Puíg L; Reich K; van de Kerkhof P; Wu HL; Richter S; Jardon S; Gisondi P
    Dermatol Ther (Heidelb); 2022 Jan; 12(1):61-78. PubMed ID: 34704231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional impairment measurement in psoriatic arthritis: Importance and challenges.
    Mease P; Strand V; Gladman D
    Semin Arthritis Rheum; 2018 Dec; 48(3):436-448. PubMed ID: 30029795
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The musculoskeletal impairment negatively impacts the quality of life of children and adolescents with psoriasis.
    Meneghetti TC; Padilha TMH; Azevedo VF; Cat MNL; Sarolli BMS; de Carvalho VO
    Adv Rheumatol; 2020 Jun; 60(1):33. PubMed ID: 32552795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement properties of instruments assessing psoriatic arthritis symptoms for psoriasis clinical trials: a systematic literature review.
    Perez-Chada LM; Balak D; Cohen JM; Ogdie A; Merola JF; Gottlieb AB
    Expert Rev Clin Immunol; 2020 Mar; 16(3):267-283. PubMed ID: 32037912
    [No Abstract]   [Full Text] [Related]  

  • 19. Quantifying harmful effects of psoriatic diseases on quality of life: Cardio-metabolic outcomes in psoriatic arthritis study (COMPASS).
    Dalal DS; Lin YC; Brennan DM; Borkar N; Korman N; Husni ME
    Semin Arthritis Rheum; 2015 Jun; 44(6):641-5. PubMed ID: 26058346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound-aided diagnosis of preclinical phases of psoriatic arthritis in biologic-naïve psoriasis patients with or without arthralgia.
    Yen TH; Tseng CW; Chen HH; Wu YD; Yen CY; Chiu CS; Juan CK; Lai KL
    Clin Exp Rheumatol; 2022 Jul; 40(7):1273-1279. PubMed ID: 34369361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.